A next-generation regenerative peptide designed to help reduce chronic inflammation, support nerve health, and activate your body’s natural repair systems.
Cibinetide Acetate (ARA-290) is a synthetic peptide derived from erythropoietin (EPO) that delivers the tissue-protective and anti-inflammatory benefits of EPO—without stimulating red blood cell production.
Originally developed to help treat diabetic nerve damage, Cibinetide is now being explored for its ability to support nerve repair, reduce chronic inflammation, promote healthy tissue recovery, and assist with immune regulation across a variety of inflammatory conditions.
Cibinetide works by selectively activating the Innate Repair Receptor (IRR)—a key part of the body’s built-in healing system. Once activated, this receptor helps reduce oxidative stress, limit cellular damage, regulate inflammation, and promote healthy tissue repair.
Unlike traditional erythropoietin therapies, Cibinetide does not stimulate red blood cell production. Instead, it focuses exclusively on regenerative and protective pathways, providing therapeutic benefits without increasing hematocrit levels.
May help reduce neuropathic pain while supporting healthier nerve signaling and recovery from nerve-related injuries or conditions.
Supports the body's natural ability to regulate inflammatory responses, helping calm chronic inflammation without broadly suppressing the immune system.
Promotes cellular protection and tissue healing by reducing oxidative stress and supporting your body's regenerative processes.
Helps regulate immune activity, making it a promising option for individuals managing chronic inflammatory or autoimmune-related symptoms.
Cibinetide is commonly considered for patients who are:
Its unique mechanism allows treatment to focus on repairing damaged tissue—not simply masking symptoms.
One of Cibinetide’s most unique qualities is its ability to activate the body’s repair pathways without affecting red blood cell production. This selective action allows it to deliver regenerative benefits while avoiding many of the concerns associated with traditional erythropoietin-based therapies.
As research continues to expand, Cibinetide is gaining attention for its potential role in regenerative medicine, nerve recovery, and long-term inflammatory health.
Pick a time online — most slots open within 48 hours.
Meet your MD over video or phone. Bloodwork is reviewed live.
Medication shipped discreetly to your door.
Contact us today to schedule your consultation. A practitioner will reach out within one business day — no pressure, no pitch.
(386) 999-9999
51 Dunlawton Ave, Port Orange, FL 32127
Mon–Fri · 9am – 6pm ET